UPDATE 1-No early win for Sanofi, Regeneron cholesterol drug in study

Nov 17 (Reuters) - Sanofi and Regeneron
Pharmaceuticals said on Thursday they would continue a
large clinical outcomes study with their injectable
cholesterol-lowering drug Praluent, confounding...